Idiopathic Hypersomnia
Idiopathic Hypersomnia (IH) is a rare sleep disorder that causes excessive daytime sleepiness even after a full night's sleep, making it difficult for individuals to stay awake and alert during the day.
Idiopathic Hypersomnia: TAK-360 Study
We are testing a new medication, TAK-360, for people with idiopathic hypersomnia to see if it helps reduce excessive daytime sleepiness and improve overall condition. The study will also monitor the safety and tolerability of the treatment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 70 years old?
- Do you have a current diagnosis of IH (Idiopathic Hypersomnia) confirmed within the last 5 years?
- Are you pregnant or breastfeeding?
- Have you had cancer in the past 5 years?
- Do you have signs of substance abuse?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Tak-360
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Adamon
Adamon Inject
Adamon Kaps
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire De Montpellier
Hôpital Gui De Chauliac Centre des Troubles du Sommeil Service de Neurologie
Montpellier, France
Centre Hospitalier Universitaire De Nantes
Service de Neurophysiologie clinique
Orvault, France
Assistance Publique Hopitaux De Paris
Hôpital Pitié-Salpêtrière Service des pathologies du sommeil
Salpêtrière, France
Sponsor: Takeda Development Center Americas Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.